Natural Eyes Floaters Relief

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Natural Eyes Floaters Relief
Generic name: CHELIDONIUM, EUPHRASIA, KALI SULPH, NATRUM MURIATICUM, PHOSPHORUS, PHYSOSTIGMA, SEPIA, SILICEA
Manufacturer: TRP Company
Product type: HUMAN OTC DRUG
SPL set ID: 445dc831-195e-4b25-e063-6294a90a6efd
SPL ID: 445dc839-50b1-efd8-e063-6394a90ac00b
Version: 1
Effective date: 2025-11-24
Source export date: 2026-09-28
Source partition: 8
Source file: https://download.open.fda.gov/drug/label/drug-label-0008-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/ae3816359e336a5de4f44607730a3d12ceb61ffa012a132189ceda22541b38ee/drug-label-0008-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:55:55

Harmonized routes table
Harmonized routes
ORAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 16 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
brand name		Natural Eyes Floaters Relief	openfda.brand_name
generic name		CHELIDONIUM, EUPHRASIA, KALI SULPH, NATRUM MURIATICUM, PHOSPHORUS, PHYSOSTIGMA, SEPIA, SILICEA	openfda.generic_name
manufacturer name		TRP Company	openfda.manufacturer_name
ndc	package	17312-478-14	openfda.package_ndc
ndc	product	17312-478	openfda.product_ndc
ndc11	package	17312047814	derived:openfda.package_ndc
spl id		445dc839-50b1-efd8-e063-6394a90ac00b	id
spl set id		445dc831-195e-4b25-e063-6294a90a6efd	set_id
unii		27YLU75U4W	openfda.unii
unii		C9642I91WL	openfda.unii
unii		7E889U5RNN	openfda.unii
unii		QDL83WN8C2	openfda.unii
unii		ETJ7Z6XBU4	openfda.unii
unii		CJV9E9IIOA	openfda.unii
unii		451W47IQ8X	openfda.unii
unii		1K573LC5TV	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings: A PHYSICIAN SHOULD ALWAYS BE CONSULTEDTO RULE OUT SERIOUS CAUSES. This product is intended to complement, not replace, standard medical treatment. Initial worsening of symptoms may occur. This product is intended to be taken orally. Do not use in eyes or nose. If pregnant or breast-feeding, ask a health professional before use. Do not use if: You frequently contract infections that do not clear up easily. You experience eye pain or changes in vision. Keep out of reach of children. In case of accidental overdose, get medical help or contact a Poison Control Center right away. Stop use and ask a doctor if: You experience eye pain or change in vision, continued floaters, or irritation of the eye. The condition worsens. Symptoms last longer than 72 hours.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.